GAP-independent functions of DLC1 in metastasis

被引:31
作者
Barras, David [1 ]
Widmann, Christian [1 ]
机构
[1] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
DLC1; RhoGAP; GAP-independent; Migration; Invasion; Metastasis; GTPASE-ACTIVATING PROTEIN; CANCER; DLC1; TUMOR-SUPPRESSOR GENE; FOCAL ADHESION-LOCALIZATION; CONTROLS CELL-MIGRATION; RHO-GTPASES; ALPHA-CATENIN; PLC-DELTA(1)-BINDING PROTEIN; ADHERENS JUNCTIONS; CARCINOMA CELLS;
D O I
10.1007/s10555-013-9458-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastases are responsible for most cancer-related deaths. One of the hallmarks of metastatic cells is increased motility and migration through extracellular matrixes. These processes rely on specific small GTPases, in particular those of the Rho family. Deleted in liver cancer-1 (DLC1) is a tumor suppressor that bears a RhoGAP activity. This protein is lost in most cancers, allowing malignant cells to proliferate and disseminate in a Rho-dependent manner. However, DLC1 is also a scaffold protein involved in alternative pathways leading to tumor and metastasis suppressor activities. Recently, substantial information has been gathered on these mechanisms and this review is aiming at describing the potential and known alternative GAP-independent mechanisms allowing DLC1 to impair migration, invasion, and metastasis formation.
引用
收藏
页码:87 / 100
页数:14
相关论文
共 50 条
  • [31] The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
    Basak, Pratima
    Dillon, Rachelle
    Leslie, Heather
    Raouf, Afshin
    Mowat, Michael R. A.
    BMC CANCER, 2015, 15
  • [32] MicroRNA-141-3p promoted the progression of nasopharyngeal carcinoma through targeting DLC1
    Mu, J-W
    Zhou, X-Y
    Wang, Q-J
    Han, L-H
    Jiao, J-B
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11105 - 11113
  • [33] Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process
    Shih, Yi-Ping
    Yuan, Sarah Y.
    Lo, Su Hao
    CANCER LETTERS, 2017, 398 : 46 - 51
  • [34] Uncovering the Rare Variants of DLC1 Isoform 1 and Their Functional Effects in a Chinese Sporadic Congenital Heart Disease Cohort
    Lin, Bin
    Wang, Yufeng
    Wang, Zhen
    Tan, Huilian
    Kong, Xianghua
    Shu, Yang
    Zhang, Yuchao
    Huang, Yun
    Zhu, Yufei
    Xu, Heng
    Wang, Zhiqiang
    Wang, Ping
    Ning, Guang
    Kong, Xiangyin
    Hu, Guohong
    Hu, Landian
    PLOS ONE, 2014, 9 (02):
  • [35] Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application
    Ren, Guanghui
    Li, Guorong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 182 : 264 - 275
  • [36] The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
    Sanchez-Solana, Beatriz
    Wang, Dunrui
    Qian, Xiaolan
    Velayoudame, Parthibane
    Simanshu, Dhirendra K.
    Acharya, Jairaj K.
    Lowy, Douglas R.
    MOLECULAR CANCER, 2021, 20 (01)
  • [37] Tensin1 positively regulates RhoA activity through its interaction with DLC1
    Shih, Yi-Ping
    Sun, Peng
    Wang, Aifeng
    Lo, Su Hao
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (12): : 3258 - 3265
  • [38] Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
    Su, Yuqi
    Lin, Li
    Zhang, Jingwen
    Jiang, Yaqi
    Pan, Changqie
    Sun, Li
    Duan, Jiangman
    Liao, Wangjun
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 5771 - 5779
  • [39] DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling
    Scholz, Rolf-Peter
    Regner, Jennifer
    Theil, Anke
    Erlmann, Patrik
    Holeiter, Gerlinde
    Jaehne, Ruth
    Schmid, Simone
    Hausser, Angelika
    Olayioye, Monilola A.
    JOURNAL OF CELL SCIENCE, 2009, 122 (01) : 92 - 102
  • [40] Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma
    Xie, Cheng-Rong
    Sun, Hong-Guang
    Sun, Yu
    Zhao, Wen-Xiu
    Zhang, Sheng
    Wang, Xiao-Min
    Yin, Zhen-Yu
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4203 - 4209